Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences [Yahoo! Finance]
Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ:AMEX Investor Relations:
ir.citiuspharma.com
Company Research
Source: Yahoo! Finance
company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two upcoming investor conferences. Citius Chairman and CEO Leonard Mazur will present at the BIO CEO and Investor Conference on February 26-27, 2024 , and the Sidoti Small-Cap Virtual Conference on March 13-14, 2024 BIO CEO and Investor Conference Details: Presentation: 9:45 a m ET on Tuesday, February 27, 2024 Location: New York Marriott Marquis, New York City R egistration: A vailable on the conference website Sidoti Small-Cap Virtual Conference Details: Presentation: 1:45 pm ET on Wednesday, March 13, 2024 Location: Virtual R egistration: A vailable on the conference website 1x1 meetings: Requests available through a Sidoti representative About Citius Pharmaceuticals, Inc. Citius Pharma is a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care p
Show less
Read more
Impact Snapshot
Event Time:
CTXR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTXR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTXR alerts
High impacting Citius Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CTXR
News
- Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct OfferingPR Newswire
- Citius Pharmaceuticals Announces $15 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Citius Pharmaceuticals Announces $15 Million Registered Direct OfferingPR Newswire
- Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma [Yahoo! Finance]Yahoo! Finance
CTXR
Earnings
- 2/14/24 - Miss
CTXR
Analyst Actions
- 2/14/24 - HC Wainwright
CTXR
Sec Filings
- 4/30/24 - Form 8-K
- 4/26/24 - Form 424B5
- 4/5/24 - Form 8-K
- CTXR's page on the SEC website